Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Constellation Brands
STZ
US Stock MarketDetailed Quotes
CRVO CervoMed
- 9.260
- +0.620+7.18%
Trading Apr 28 12:49 ET
80.59MMarket Cap-4.58P/E (TTM)
9.940High8.590Low265.12KVolume8.610Open8.640Pre Close2.47MTurnover4.57%Turnover RatioLossP/E (Static)8.70MShares25.69052wk High2.06P/B53.68MFloat Cap1.80052wk Low--Dividend TTM5.80MShs Float3375000000.000Historical High--Div YieldTTM15.63%Amplitude1.800Historical Low9.327Avg Price1Lot Size
About CervoMed Company
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.
Company Profile
SymbolCRVO
Company NameCervoMed
Listing DateNov 9, 2016
Founded1995
CEODr. John J. Alam, M.D.
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address20 Park Plaza,Suite 424
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02216
Phone1-617-744-4400
Websitehttp://www.cervomed.com
Company Executives
- Name
- Position
- Salary
- Dr. John J. Alam, M.D.
- Chief Executive Officer, President and Director
- 815.16K
- William R. Elder
- General Counsel, Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
- 468.35K
- Dr. Robert Joseph Cobuzzi, Jr,PhD
- Chief Operating Officer and Director
- 703.12K
- Kelly Blackburn, M.H.A
- Executive Vice President, Clinical Development
- 465.74K
- Dr. Mark De Rosch, B.S.,M.S.,PhD
- Senior Vice President, Regulatory and Government Affairs and Program Management
- --
- Dr. Joshua S. Boger,PhD
- Chairman of the Board
- --
- Dr. Sylvie Gregoire,Pharm.D.
- Director
- 376.94K
- Jane H. Hollingsworth
- Independent Director
- 82.91K
- Jeffrey V. Poulton
- Independent Director
- 47.20K
- Frank Zavrl
- Independent Director
- 47.76K
- Dr. Marwan Noel Sabbagh, M.D.
- Independent Director
- 41.15K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
